+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

Hope APFED/AAAAI Grant Award

American Academy of Allergy, Asthma & Immunology (AAAAI)

The 2026 Hope APFED/AAAAI Grant Award was established to allow investigators from a variety of disciplines to initiate new projects relevant to Eosinophilic Disorders, excluding asthma, rhinitis and eczema. Successful applications will focus on the development of new ideas which are likely to lead to future external funding.

The 2026 Hope APFED/AAAAI Grant Award is a collaborative award program between the American Academy of Allergy, Asthma & Immunology (AAAAI) and the American Partnership for Eosinophilic Disorders (APFED). The award program is administered by the AAAAI and equally funded by each Association.

What support does the award provide?

The 2026 Hope APFED/AAAAI Grant Award provides a total of $140,000 paid out in four equal payments of $35,000 over two years. Continuation into the second year for the grant is subject to demonstrating satisfactory progress through an annual report. The full award term is July 1, 2026, to June 30, 2028.

Financial Conditions:

The grant may be used for the purchase of supplies and services directly related to the approved research endeavors.
Award funds may be used for the salary and fringe benefit costs of personnel other than the applicant. Fringe benefit costs may only be expended upon the stipulation that they not be obtained from another source.
Funds may not be used for institutional indirect costs or to acquire administrative or clerical support.
No more than 30% of the total award budget may be used to fund the purchase of permanent equipment.
Overhead or indirect costs are not permitted.
No award funds shall be used for the purchase of furniture, computers, the construction or renovation of facilities, payment of honoraria or membership dues, purchase of textbooks or periodicals or payment for secretarial support.

Other Conditions:

A progress and a financial report will be requested after the first year of the award and are required to be submitted on time for determination of continuation of the award into the second year.
Recipient will submit a final report at the end of the second-year outlining project results and anticipated next steps.
Recipient should plan to make a presentation of their project status and results at both the EOS Connection Annual Conference and AAAAI Annual Meeting one of the years they will be the recipient of grant funding.
1. A maximum of $1,000 per year of the grant award should be set aside for the travel expenses for this/these conference/meetings.

Citizenship:

At the time of application, candidates must be United States citizens or foreign nationals holding one of the following visa immigration statuses:

Permanent resident (Green Card),
Exchange visitor (J-1),
Temporary worker in a specialty occupation (H-1, H-1B),
Canadian or Mexican citizen engaging in professional activities (TC or TN),
Temporary worker with extraordinary abilities in the sciences (O-1).
Non-citizens must submit a notarized copy of proof of possession of a Green Card or J-1, H-1, H-1B, TC, TN or O-1 visas.

At the time of application and throughout the award, an applicant/recipient must be employed by a U.S. institution.

Deadline:

Applications must be submitted in a single pdf file by October 31, 2025, 3:00 pm CT. Applicants will be notified regarding status of their application in January 2026.

Selection:

Review and decision will be made by a Joint Review Committee of equal representatives from APFED and AAAAI.

AI Based Application Success Predictor

Faculty Development Award (Mentored Early-Career)

Offers $300,000 over three years, awarded to junior faculty to establish themselves as independent physician-scientists.

Requires a faculty appointment, mentor, and eligibility within around five years of completing training. The award strongly emphasizes health equity, diversity, and inclusion.

Award to Sustain Research Excellence (Bridge Grant)

Provides $100,000 for one year to investigators whose NIH or AHRQ R01 applications were scored but not funded (A0). This bridge funding supports revising and resubmitting the proposal, paired with expert review and feedback.

Specialized Disease Research Grants

Hope APFED/AAAAI Grant: $140,000 over 2 years to support early-stage research in eosinophilic disorders.

Allergic Respiratory Diseases Research Award (with American Lung Association): $75,000 over 2 years for faculty-led research in allergic respiratory diseases.

Drug Hypersensitivity Research Grant

Supports up to three projects addressing drug allergy and hypersensitivity mechanisms. Recent cycles have awarded funds up to ~$150,000.

Honorary Awards & Recognition

These include the Distinguished Scientist Award, Mentorship Award, Distinguished Clinician Award, and lifetime contribution honors—marking significant peer recognition and leadership in the field.

Why AAAAI Awards Signal Future Impact

Award Type

Predictive Value for Career Success

Faculty Development Award

Accelerates independence; builds research portfolio early.

Bridge Grant

Helps sustain research momentum; boosts R01 competitiveness.

Specialized Research Grants

Signals focus and impact in high-priority allergy/immunology fields.

Honorary & Mentorship Awards

Reflects peer recognition, leadership, and mentorship excellence.

Real-World Outcomes

Dr. Kari Nadeau received the AAAAI Award for Junior Faculty early in her career and went on to broad recognition, including membership in the National Academy of Medicine.

Dr. Marc Rothenberg, recipient of the Distinguished Scientist Award, has driven translational breakthroughs such as FDA-approved treatments for eosinophilic esophagitis—highlighting how AAAAI recognition aligns with high-impact science.

Summary

Securing an AAAAI Foundation award—whether a Junior Faculty Development grant, bridge funding, or a specialized research grant—is a powerful marker of trajectory. It reflects competitive rigor, institutional support, translational intent, and peer validation. Honorary awards further elevate visibility and leadership within allergy/immunology.

Specialties

Immunology

Eligibility Requirements

Applicants must meet the following requirements to be eligible for the 2026 Hope APFED/AAAAI Grant Award:

Applicants must be an AAAAI member in good standing at the time of application
MD, DO, Nursing Doctorate, PhD, or MD/PhD
Full-time faculty appointment as an instructor or higher level in an allergy section or division at a medical school in the United States
1. Priority will be given to applicants at or below the rank of associate professor.
Applicants must be independent, self-directed researchers for whom their institution must provide space and other resources customary for independent investigators.
1. The application must convey the commitment of the institution to the applicant and the proposed research activities.

Applicants from institutions that do not have accreditation from the AAALAC, USDA and/or IACUC are not eligible to apply.

Eligible Countries:

United States

Sponsor Details

Sponsor Institute/Organizations: American Academy of Allergy, Asthma & Immunology (AAAAI)

Sponsor Type: Corporate/Non-Profit

Address: 555 East Wells Street Suite 1100 Milwaukee, WI

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity